Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2026-03-11 @ 2:53 PM
Study NCT ID:
NCT02638220
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2015-11-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
Sponsor:
Travere Therapeutics, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cerebrotendinous Xanthomatosis (CTX) | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Cerebrotendinous Xanthomatosis | View |
| None | CTX Prevalence Study | View |
| None | CTX | View |
| None | Idiopathic Bilateral Cataracts | View |
| None | Cataracts | View |
| None | Bilateral Cataracts | View |
| None | Early-Onset Idiopathic Bilateral Cataracts | View |
| None | Observational Study | View |
| None | Ophthalmology | View |